Medtronic's Percept PC DBS Study for Treatment Resistant Depression Initiated
A new study is investigating the use of Medtronic's Percept PC deep brain stimulation device for treatment resistant depression, focusing on local field potentials.
Asset / Drug
Drug and asset intelligence for Medtronic with 14 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Device Therapy
Medtronic is conducting a feasibility study to evaluate the efficacy of Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT) compared to standard LBBAP in heart failure patients.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.